Close Menu

More articles about Infectious Disease

MTTC links up with iBridge Network; ViroStatics licenses compound library from University of Siena; Ben-Gurion University inks research pact with Bayer CropScience, and more …

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The first in a series of programs will support studies of HIV-1 persistence, including host and pathogen genetics.

Nearly $14 million next year will support centers to study malaria and develop gene-based diagnostics.

Short Reads: Apr 7, 2009

Premium

Genome Analysis Centre, University of Barcelona, NIAID, Massachusetts Institute of Technology, J. Craig Venter Institute, University of Maryland, SeqWright, Hologic, BioReference Laboratories, GeneDx, University of Michigan, Genomatix Software, NHGRI

Agilent's Human CNV Association 2x105K microarray, based on a design by the Wellcome Trust Case Control Consortium, is the company's second catalog CNV chip and was designed for studying associations between genomic CNVs and disease.

BioArray Briefs: 2009.04.07

Premium

CGC Genetics, Nuvera Biosciences, Veridex, ImaGenes, CapitalBio, Fisher Healthcare, Osmetech, National Institutes of Health, Clinical Data, Cogenics, UK Biotechnology and Biological Sciences Research Council

JCVI, MIT, and the University of Maryland, Baltimore, will use the funds to conduct genome sequencing projects.

The university will help an international effort to study the genetics involved in malnutrition.

Several of the company's microarray-based tests have been certified in China and Europe.

Researchers from France and India reported today in the New England Journal of Medicine that human papillomavirus testing significantly decreased cervical cancer deaths among previously unscreened women in rural India, whereas cytology and visual screening methods had little effect on mortality.

An appeals court has ruled in favor of Qiagen in an antitrust suit brought by Third Wave over HPV tests.

The UK company will use the Seegene DPO technology to develop diagnostic screening panels.

Bioinformatics

Researchers from Kaiser Permanente and the National Cancer Institute who co-tested nearly 600,000 women using Pap and HPV tests over five years have concluded that such testing doesn't lead to an excess of HPV positive women requiring lengthy follow-up.

The grant will support the development of the firm's pressure cycling technology in sample prep for microbiome studies.

NKT licensed the IP from Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, and Massachusetts General Hospital. As a result, each of the Harvard Med-affiliated institutes has been awarded an undisclosed equity stake in the company.

Although the developers note that the protocol particularly benefits the sequencing of AT-rich genomes, they say that it is also quicker than the standard method, which requires PCR amplification, and "should be used routinely to prepare libraries for Genome Analyzer sequencing."

Hologic joins Qiagen as the only firm to receive FDA clearance to sell an HPV molecular diagnostic test in the US. Hologic's shares went up and Qiagen's went down following the news.

Using bioinformatics, an American research team has found that more than a dozen species of Rickettsia bacteria — both pathogenic and non-pathogenic — share a conserved type IV secretion system.

Pages

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.